Related Experiment Video
Updated: May 6, 2026

12:55
Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
Published on: February 16, 2015
17.9K
Apoptosis: implications of basic research for clinical oncology
I Tamm1, F Schriever, B Dörken
1Medizinische Klinik mit Schwerpunkt Hamatologie, Onkologie, und Tumorimmunologie, Charité, Berlin, Germany. tamm@rrk-berlin.de
The Lancet. Oncology
|March 22, 2002
Summary
Apoptosis, or programmed cell death, is crucial in preventing diseases like cancer. Understanding its mechanisms offers new diagnostic and therapeutic strategies for various human conditions.
Area of Science:
- Molecular Biology
- Cell Biology
- Pathology
Background:
- Apoptosis plays a critical role in maintaining cellular homeostasis and preventing disease.
- Dysregulation of apoptosis is implicated in carcinogenesis, immune evasion, and resistance to cancer therapies.
- The fundamental molecular machinery of apoptosis is conserved across animal species.
Purpose of the Study:
- To provide an updated overview of the key molecular players regulating apoptosis.
- To review the involvement of apoptosis in the pathogenesis of various human diseases.
- To highlight novel diagnostic and therapeutic avenues emerging from apoptosis research.
Main Methods:
- This review synthesizes findings from recent studies on apoptosis.
- It focuses on the core protein machinery governing the cell death pathway.
- The review integrates basic research with clinical implications.
Main Results:
- Suppression of apoptosis contributes to cancer development through mechanisms like mutation accumulation and growth factor independence.
- Defects in apoptosis confer resistance to chemotherapy and radiation therapy.
- Key apoptosis-regulating proteins represent conserved targets for intervention.
Conclusions:
- Apoptosis is a central process in human health and disease.
- Targeting apoptosis pathways holds significant promise for developing innovative diagnostics and therapeutics.
- Continued basic research is essential for translating these findings into clinical practice.
Related Concept Videos
Cancer Therapies
8.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.6K
Apoptosis
12.3K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
12.3K
The Extrinsic Apoptotic Pathway
6.2K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.2K
The Intrinsic Apoptotic Pathway
6.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
Phagocytosis of Apoptotic Cells
3.9K
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized...
Normal cells contain receptors that prevent them from being recognized...
3.9K
Cellular Injury V: Apoptosis and Autophagy
121
Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
121

